PHARMACEUTICAL IP

  • Our Offering
    • Fractional in-house
    • Start-ups
    • Established pharma
    • International IP counsel
    • Investors
    • Due diligence
  • Fractional in-house
  • Sectors
    • Pharmaceuticals
    • Biotechnology
    • Biologics
    • Cell & gene therapies
    • AI drug discovery
    • Chemistry
  • Insights
  • About us
    • Our team
    • Join us
    • Contact us
  • Our Offering
    • Fractional in-house
    • Start-ups
    • Established pharma
    • International IP counsel
    • Investors
    • Due diligence
  • Fractional in-house
  • Sectors
    • Pharmaceuticals
    • Biotechnology
    • Biologics
    • Cell & gene therapies
    • AI drug discovery
    • Chemistry
  • Insights
  • About us
    • Our team
    • Join us
    • Contact us
  • Our offering
  • Fractional in-house
  • Sectors
  • Insights
  • Our team
  • Join us
  • Our offering
  • Fractional in-house
  • Sectors
  • Insights
  • Our team
  • Join us

Investors

At Evolve, we understand that intellectual property assessment is a crucial component of investment decision-making in the life sciences sector. Our specialised investor services provide you with clear, actionable insights into the strength, scope, and competitive positioning of potential investments’ IP portfolios.

We offer comprehensive IP landscape analysis to identify potential risks and opportunities within your target investment areas. Our experienced attorneys can evaluate the quality and durability of patent protection, assess freedom-to-operate concerns, and identify potential challenges that could impact valuations. By leveraging our deep scientific expertise and commercial insight, we help you make informed investment decisions with confidence.

Strategic IP assessment

Our team provides detailed analysis of IP assets to inform your investment. We conduct thorough evaluations of patent portfolios, examining critical factors such as claim scope, territorial coverage, patent term, and resilience against potential challenges. Our assessments provide insights into how the IP aligns with market opportunities and competitive dynamics, helping you identify both risks and hidden value.

Fractional IP support

When an asset is acquired, the IP portfolio may require timely decision making and actions to bring it into line with your commercial priorities. We provide a fractional in-house service delivering senior head of IP expertise on a flexible and cost-effective basis. We can support your new acquisition on an interim or permanent basis to help manage day-to-day IP needs, and handle the operational complexities while providing expert strategic direction.

Due diligence support

For investors conducting due diligence, we deliver clear, comprehensive IP analysis that highlights strengths and potential risks. We can assess the alignment between the company’s IP strategy and its business objectives, evaluate the robustness of its freedom-to-operate position, and identify opportunities to strengthen protection. Our attorneys have extensive experience communicating complex IP matters in terms that resonate with business leaders and stakeholders, ensuring you receive practical insights that support your decision-making process.

Evolve IP is able to offer commercially focused, strategic, and clear advice on complex patent portfolios

I recommend Evolve for chemical/pharma patent issues – whether prosecution or complex FTO or loss of exclusivity considerations.

I chose Evolve because they have unique expertise in pharma IP. They are friendly and knowledgeable and provide practical advice.

evolve® is a trading entity of Evolve Intellectual Property Limited. Evolve Intellectual Property Limited is regulated by the Intellectual Property Regulation Board (IPReg). Details of the UK professional rules can be found on the IPReg website

registered address: 49 Greek Street, London, England, W1D 4EG

website out of house

© 2025 All Rights Reserved

Keep in touch

Contact Us